gefitinib

You have access
Targeted Treatment of HPV16-positive and -negative SCC Cells With Small Molecule Tyrosine Kinase Inhibitors and Everolimus Affects MMP2 and MMP14 Expression
LENA HUBER, RICHARD BIRK, MANUEL KNUETTEL, NICOLE ROTTER, CHRISTOPH ADERHOLD, CLAUDIA SCHERL, ANNE LAMMERT, FREDERIC JUNGBAUER and BENEDIKT KRAMER

Anticancer Research July 2022, 42 (7) 3403-3411; DOI: https://doi.org/10.21873/anticanres.15827
You have access
Real-life Effectiveness of Afatinib Versus Gefitinib in Patients With Non-small-cell Lung Cancer: A Czech Multicentre Study
MARTIN SVATON, MONIKA BRATOVA, ONDREJ FISCHER, JANA KREJCI, LEONA KOUBKOVA, MARKETA CERNOVSKA, MICHAL HRNCIARIK, MILADA ZEMANOVA, HELENA COUPKOVA, BEDRICH PORZER, DANIEL DOLEZAL, TANA TUZOVA, KAROLINA HURDALKOVA, MAGDA BARINOVA and JANA SKRICKOVA

Anticancer Research April 2021, 41 (4) 2059-2065; DOI: https://doi.org/10.21873/anticanres.14975
You have access
Apoptosis-related Proteins Are Altered by Selective Tyrosine Kinase Inhibitors and Everolimus in HPV-dependent SCC
RICHARD BIRK, ANGELA SCHELL, CHRISTOPH ADERHOLD, STEPHAN HOCH, LENA HUBER, CORNELIA EMIKA MUELLER, ANNE LAMMERT, CLAUDIA SCHERL, NICOLE ROTTER, J. ULRICH SOMMER and BENEDIKT KRAMER

Anticancer Research November 2020, 40 (11) 6195-6203; DOI: https://doi.org/10.21873/anticanres.14639
You have access
Tyrosine Kinase Inhibitors and Everolimus Reduce IGF1R Expression in HPV16-positive and -negative Squamous Cell Carcinoma
BENDIKT KRAMER, ANGELA SCHELL, CHRISTOPH ADERHOLD, LENA HUBER, C. EMIKA MUELLER, NICOLE ROTTER and RICHARD BIRK

Anticancer Research July 2020, 40 (7) 3847-3855; DOI: https://doi.org/10.21873/anticanres.14374
You have access
Effect of Small-molecule Tyrosine Kinase Inhibitors on PDGF-AA/BB and PDGFRα/β Expression in SCC According to HPV16 Status
LENA HUBER, RICHARD BIRK, NICOLE ROTTER, CHRISTOPH ADERHOLD, ANNE LAMMERT, FREDERIC JUNGBAUER and BENEDIKT KRAMER

Anticancer Research February 2020, 40 (2) 825-835; DOI: https://doi.org/10.21873/anticanres.14014
You have access
Tetrandrine Increases the Sensitivity of Human Lung Adenocarcinoma PC14 Cells to Gefitinib by Lysosomal Inhibition
EIKO SATO, SINYA OHTA, KENJIRO KAWAKAMI, MANA IKEDA, TATSUO TAKAHASHI, SHINJIRO KOBAYASHI and MASAAKI NOMURA

Anticancer Research December 2019, 39 (12) 6585-6593; DOI: https://doi.org/10.21873/anticanres.13874
You have access
Tyrosine Kinase Inhibitors Imatinib and Erlotinib Increase Apoptosis of Antimitotic Drug-resistant KBV20C Cells Without Inhibiting P-gp
JI YEONG KIM, HYUNG SIK KIM and SUNGPIL YOON

Anticancer Research July 2019, 39 (7) 3785-3793; DOI: https://doi.org/10.21873/anticanres.13527
You have access
Upfront Cranial Radiotherapy Followed by Erlotinib Positively Affects Clinical Outcomes of Epidermal Growth Factor Receptor-mutant Non-small Cell Lung Cancer With Brain Metastases
KOICHI SARUWATARI, TOKUNORI IKEDA, SHO SAEKI, NAOKI SHINGU, KOSUKE IMAMURA, TAIYOU KOMATU, SUNAO USHIJIMA, HIROTAKA MARUYAMA, KOSUKE KASHIWABARA, YUSUKE TOMITA, HIDENORI ICHIYASU, KAZUHIKO FUJII and TAKURO SAKAGAMI

Anticancer Research February 2019, 39 (2) 923-931; DOI: https://doi.org/10.21873/anticanres.13195
You have access
Tyrosine Kinase Inhibition in HPV-related Squamous Cell Carcinoma Reveals Beneficial Expression of cKIT and Src
BENEDIKT KRAMER, MARCEL KNEISSLE, RICHARD BIRK, NICOLE ROTTER and CHRISTOPH ADERHOLD

Anticancer Research May 2018, 38 (5) 2723-2731;
You have access
Phenethyl Isothiocyanate Induces Apoptotic Cell Death Through the Mitochondria-dependent Pathway in Gefitinib-resistant NCI-H460 Human Lung Cancer Cells In Vitro
TE-CHUN HSIA, YI-PING HUANG, YI-WEN JIANG, HSIN-YU CHEN, ZHENG-YU CHENG, YUNG-TING HSIAO, CHENG-YEN CHEN, SHU-FEN PENG, FU-SHIN CHUEH, YU-CHENG CHOU and JING-GUNG CHUNG

Anticancer Research April 2018, 38 (4) 2137-2147;

Main menu

User menu

Search

gefitinib

Pages